Novolog (Pharm-Up 1966) Informe acción TASE:NVLG Capitalización de mercado
₪801.8m
Novolog (Pharm-Up 1966) Ltd
Informe acción TASE:NVLG
Capitalización de mercado: ₪801.8m
Resumen de acción NVLG Novolog (Pharm-Up 1966) Ltd presta servicios sanitarios en Israel. Saber más
Análisis de riesgos Ver todos los controles de riesgos Competidores de Novolog (Pharm-Up 1966) Ltd Historial de precios y rendimiento
Resumen de todos los máximos históricos, cambios y caídas de precios de Novolog (Pharm-Up 1966) Precios históricos de las acciones Precio actual de la acción ₪1.57 Máximo en las últimas 52 semanas ₪1.70 Mínimo de 52 semanas ₪1.27 Beta 0.36 1Cambio en 1 mes 7.76% Variación en 3 meses 11.66% Cambio de 1 año -0.44% 3Variación en 3 años -46.58% Variación en 5 años -5.14% Variación desde la OPV -3.68%
Noticias y actualizaciones recientes
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21 Ver más actualizaciones
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2024 Results on May 21, 2024 May 14
Full year 2023 earnings released: ₪0.082 loss per share (vs ₪0.094 profit in FY 2022) Mar 27
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2023 Results on Mar 26, 2024 Mar 06
New minor risk - Share price stability Feb 10
Third quarter 2023 earnings released: EPS: ₪0.001 (vs ₪0.02 in 3Q 2022) Nov 22
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Nov 05
Investor sentiment improves as stock rises 17% Nov 05
Second quarter 2023 earnings released: EPS: ₪0.023 (vs ₪0.024 in 2Q 2022) Aug 23
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital Jul 25
First quarter 2023 earnings released: ₪0.02 loss per share (vs ₪0.024 profit in 1Q 2022) Jun 01
Investor sentiment deteriorates as stock falls 15% Mar 30
Full year 2022 earnings released: EPS: ₪0.094 (vs ₪0.084 in FY 2021) Mar 21
Investor sentiment deteriorates as stock falls 17% Feb 26
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2022 Results on Mar 20, 2023 Feb 07
Investor sentiment deteriorates as stock falls 15% Jan 30
Novolog (Pharm-Up 1966) Ltd Appoints Tami Gottlieb as an Independent Non-Executive Director Jan 17
Third quarter 2022 earnings released: EPS: ₪0.02 (vs ₪0.02 in 3Q 2021) Nov 18
Insufficient new directors Nov 16
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2022 Results on Nov 16, 2022 Nov 02
Second quarter 2022 earnings released: EPS: ₪0.024 (vs ₪0.02 in 2Q 2021) Aug 14
Insufficient new directors Aug 01
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2022 Results on Aug 10, 2022 Jul 28
Insufficient new directors Jul 02
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 22
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2022 Results on May 18, 2022 May 19
Investor sentiment improved over the past week Apr 03
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 17
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2021 Results on Mar 14, 2022 Feb 25
Third quarter 2021 earnings released: EPS ₪0.022 (vs ₪0.021 in 3Q 2020) Nov 21
I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease May 07
Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend Apr 14
Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality Mar 24
Upcoming dividend of ₪0.032 per share Mar 23
Full year 2020 earnings released: EPS ₪0.086 (vs ₪0.026 in FY 2019) Mar 23
Novolog (Pharm-Up 1966) Ltd to Report Fiscal Year 2020 Results on Mar 17, 2021 Mar 17
Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Mar 09
How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own? Feb 15
New 90-day low: ₪2.76 Feb 01
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years Jan 25
Novolog (Pharm-Up 1966) Ltd announced that it has received ILS 119.999999 million in funding Dec 31
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid? Dec 29
With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting Dec 08
Third quarter 2020 earnings released: EPS ₪0.021 Nov 28
Market bids up stock over the past week Nov 18
New 90-day high: ₪3.20 Nov 17
New 90-day high - ₪3.09 Jul 20 Rentabilidad de los accionistas NVLG IL Healthcare Mercado IL 7D 4.6% 4.1% 3.5% 1Y -0.4% 17.2% 29.1%
Ver rendimientos de los accionistas
Rentabilidad vs. Industria: Los resultados de NVLG fueron inferiores a los de la industria IL Healthcare, que obtuvo un rendimiento del 17.2% el año pasado.
Rentabilidad vs. Mercado: NVLG obtuvo unos resultados inferiores a los del mercado IL, que fueron del 29.1% el año pasado.
Volatilidad de los precios Is NVLG's price volatile compared to industry and market? NVLG volatility NVLG Average Weekly Movement 4.2% Healthcare Industry Average Movement 3.5% Market Average Movement 4.0% 10% most volatile stocks in IL Market 7.5% 10% least volatile stocks in IL Market 2.8%
Precio estable de las acciones: NVLG no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de NVLG (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa Novolog (Pharm-Up 1966) Ltd presta servicios sanitarios en Israel. La empresa opera a través de tres divisiones: Logística, Servicios Sanitarios y Digital. La división de Logística se dedica a la importación y distribución de medicamentos y productos médicos; logística de ensayos clínicos y servicios relacionados; prestación de servicios farmacéuticos a clientes; y procesos de esterilización y validación de equipos médicos consumibles.
Mostrar más Resumen de fundamentos de Novolog (Pharm-Up 1966) Ltd ¿Cómo se comparan los beneficios e ingresos de Novolog (Pharm-Up 1966) con su capitalización de mercado? Estadísticas fundamentales de NVLG Capitalización bursátil ₪801.83m Beneficios(TTM ) -₪17.54m Ingresos (TTM ) ₪1.68b
0.5x Ratio precio-ventas (PS)
-45.7x Ratio precio-beneficio (PE) Beneficios e Ingresos Estadísticas clave de rentabilidad del último informe de resultados (TTM) Cuenta de resultados (TTM ) de NVLG Ingresos ₪1.68b Coste de los ingresos ₪1.51b Beneficio bruto ₪173.56m Otros gastos ₪191.10m Beneficios -₪17.54m
Últimos beneficios comunicados
Jun 30, 2024
Próxima fecha de beneficios
Nov 20, 2024
Beneficios por acción (BPA) -0.034 Margen bruto 10.31% Margen de beneficio neto -1.04% Ratio deuda/patrimonio 0.03%
¿Cómo se ha desempeñado NVLG a largo plazo?
Ver rendimiento histórico y comparativa Dividendos
3.7% Rentabilidad actual por dividendo
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
